Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial)
Journal article published in 2020 by
Heinz Ludwig 
,
Bela Hausmann,
Martin Schreder,
Wolfram Pönisch ,
Niklas Zojer,
Stefan Knop,
Eberhard Gunsilius,
Alexander Egle ,
Andreas Petzer,
Hermann Einsele,
Roman Hajek ,
Katja Weisel,
Karl Jochen Krenosz,
Alois Lang,
Daniel Lechner
and other authors.
,
Bela Hausmann,
Martin Schreder,
Wolfram Pönisch ,
Niklas Zojer,
Stefan Knop,
Eberhard Gunsilius,
Alexander Egle ,
Andreas Petzer,
Hermann Einsele,
Roman Hajek ,
Katja Weisel,
Karl Jochen Krenosz,
Alois Lang,
Daniel Lechner
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 